Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Study of VS-4718, a Focal Adhesion Kinase Inhibitor, in Subjects With Metastatic Non-Hematologic Malignancies

NCT01849744 is registered in ClinicalTrials.gov with Verastem, Inc. as lead sponsor.

NCT NCT01849744
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01849744 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Study of VS-4718, a Focal Adhesion Kinase Inhibitor, in Subjects With Metastatic Non-Hematologic Malignancies
Lead sponsor
Verastem, Inc.
Phase
Phase 1
Overall status
Terminated
Start date
June 30, 2013
Completion date
June 30, 2017
Enrollment
48 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic cancer, non hematologic cancers